In order for the synthesis of monoamine neurotransmitters to occur, the amino acid precursors must undergo uptake into the cells performing synthesis. This process occurs in numerous places throughout the body including the central nervous system, kidneys, liver, gastrointestinal tract, mesentery, lungs and peripheral nerves. The cation uptake ports found in the proximal convoluted renal tubule cells are a prototype for amino acid uptake (see diagram below at the top center.16)

Diagram at left: The neurotransmitters and amino acid are filtered at the glomerulous are taken up in the proximal renal tubules by the cation ports of the proximal convoluted renal tubule cells. The proximal convoluted renal tubule cells then further filter the neurotransmitters and amino acids into separate areas where the neurotransmitters are metabolized and the amino acids are synthesized into new neurotransmitters that are then either excreted into the urine or secreted into the system via the renal veins.

Neurotransmitters synthesized by the kidneys are the source of urinary serotonin and catecholamines.16, 17, 18, 19 Serotonin and the catecholamines are synthesized by the kidneys, then excreted into the urine or secreted into the system via the renal veins.20 Uptake is affected by administration of a single amino acid precursor or improperly balanced amino acid precursors and may overwhelm and compete with uptake of the other amino acids. Administration of only L-dopa inhibits uptake of 5-HTP.44 Administration of only 5-HTP has the same effect on L-dopa uptake.

So to summarize, neurotransmitter synthesis is a complicated process. If you take amino acids improperly, you can cause further imbalance in the system due to decreased synthesis, increased metabolism by MAO and COMT and/or uptake competition.

So the point of all this is this: you have to take amino acids in the right balance to achieve long term results – and that is what we will discuss next.

 

16. Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man. Br J Clin Pharmacol. 1995 Mar;39(3):327-9 Wa TC, Burns NJ, Williams BC, Freestone S, Lee MR.

17. Derivation of urinary dopamine from plasma dopa. Clin Sci (Lond). 1988 Nov;75(5):515-20 Zimlichman R, Levinson PD, Kelly G, Stull R, Keiser HR, Goldstein DS.

18. Handling of dopamine and dopamine sulfate by isolated perfused rat kidney. Am J Physiol. 1986 Jun;250(6 Pt 2):F975-9 Buu NT, Duhaime J, Kuchel O.

19. Sources of human urinary epinephrine. Kidney Int. 1997 Jan;51(1):324-7 Ziegler MG, Aung M, Kennedy B.

44. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation. Br J Pharmacol. 1996 Mar;117(6):1187-92. Soares-da-Silva P, Pinto-do-O PC.